154 related articles for article (PubMed ID: 24074052)
41. Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors.
Lazareno S; Birdsall NJ
Mol Pharmacol; 1995 Aug; 48(2):362-78. PubMed ID: 7651370
[TBL] [Abstract][Full Text] [Related]
42. Structure-based discovery of selective positive allosteric modulators of antagonists for the M
Korczynska M; Clark MJ; Valant C; Xu J; Moo EV; Albold S; Weiss DR; Torosyan H; Huang W; Kruse AC; Lyda BR; May LT; Baltos JA; Sexton PM; Kobilka BK; Christopoulos A; Shoichet BK; Sunahara RK
Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2419-E2428. PubMed ID: 29453275
[TBL] [Abstract][Full Text] [Related]
43. Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.
Varoli L; Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Bedini A; Fazio N; Spampinato S
Bioorg Med Chem Lett; 2008 May; 18(9):2972-6. PubMed ID: 18395442
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.
Baraldi PG; Romagnoli R; Pavani MG; Nuñez Mdel C; Tabrizi MA; Shryock JC; Leung E; Moorman AR; Uluoglu C; Iannotta V; Merighi S; Borea PA
J Med Chem; 2003 Feb; 46(5):794-809. PubMed ID: 12593659
[TBL] [Abstract][Full Text] [Related]
45. Discovery, Optimization, and Biological Characterization of 2,3,6-Trisubstituted Pyridine-Containing M
Schubert JW; Harrison ST; Mulhearn J; Gomez R; Tynebor R; Jones K; Bunda J; Hanney B; Wai JM; Cox C; McCauley JA; Sanders JM; Magliaro B; O'Brien J; Pajkovic N; Huszar Agrapides SL; Taylor A; Gotter A; Smith SM; Uslaner J; Browne S; Risso S; Egbertson M
ChemMedChem; 2019 May; 14(9):943-951. PubMed ID: 30920765
[TBL] [Abstract][Full Text] [Related]
46. Detection and quantification of allosteric modulation of endogenous m4 muscarinic acetylcholine receptor using impedance-based label-free technology in a neuronal cell line.
Chen AN; Malone DT; Pabreja K; Sexton PM; Christopoulos A; Canals M
J Biomol Screen; 2015 Jun; 20(5):646-54. PubMed ID: 25534830
[TBL] [Abstract][Full Text] [Related]
47. An allosteric enhancer of M₄ muscarinic acetylcholine receptor function inhibits behavioral and neurochemical effects of cocaine.
Dencker D; Weikop P; Sørensen G; Woldbye DP; Wörtwein G; Wess J; Fink-Jensen A
Psychopharmacology (Berl); 2012 Nov; 224(2):277-87. PubMed ID: 22648127
[TBL] [Abstract][Full Text] [Related]
48. Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia.
Chan WY; McKinzie DL; Bose S; Mitchell SN; Witkin JM; Thompson RC; Christopoulos A; Lazareno S; Birdsall NJ; Bymaster FP; Felder CC
Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10978-83. PubMed ID: 18678919
[TBL] [Abstract][Full Text] [Related]
49. Wash-resistantly bound xanomeline inhibits acetylcholine release by persistent activation of presynaptic M(2) and M(4) muscarinic receptors in rat brain.
Machová E; Jakubík J; El-Fakahany EE; Dolezal V
J Pharmacol Exp Ther; 2007 Jul; 322(1):316-23. PubMed ID: 17446301
[TBL] [Abstract][Full Text] [Related]
50. Crystal structures of the M1 and M4 muscarinic acetylcholine receptors.
Thal DM; Sun B; Feng D; Nawaratne V; Leach K; Felder CC; Bures MG; Evans DA; Weis WI; Bachhawat P; Kobilka TS; Sexton PM; Kobilka BK; Christopoulos A
Nature; 2016 Mar; 531(7594):335-40. PubMed ID: 26958838
[TBL] [Abstract][Full Text] [Related]
51. Development of a photoactivatable allosteric ligand for the m1 muscarinic acetylcholine receptor.
Davie BJ; Sexton PM; Capuano B; Christopoulos A; Scammells PJ
ACS Chem Neurosci; 2014 Oct; 5(10):902-7. PubMed ID: 25188871
[TBL] [Abstract][Full Text] [Related]
52. A novel multivalent ligand that bridges the allosteric and orthosteric binding sites of the M2 muscarinic receptor.
Steinfeld T; Mammen M; Smith JA; Wilson RD; Jasper JR
Mol Pharmacol; 2007 Aug; 72(2):291-302. PubMed ID: 17478612
[TBL] [Abstract][Full Text] [Related]
53. Betel quid extract promotes oral cancer cell migration by activating a muscarinic M4 receptor-mediated signaling cascade involving SFKs and ERK1/2.
Chiu CC; Chen BH; Hour TC; Chiang WF; Wu YJ; Chen CY; Chen HR; Chan PT; Liu SY; Chen JY
Biochem Biophys Res Commun; 2010 Aug; 399(1):60-5. PubMed ID: 20638369
[TBL] [Abstract][Full Text] [Related]
54. Differential contribution of metabotropic glutamate receptor 5 common allosteric binding site residues to biased allosteric agonism.
Sengmany K; Hellyer SD; Christopoulos A; Lapinsky DJ; Leach K; Gregory KJ
Biochem Pharmacol; 2020 Jul; 177():114011. PubMed ID: 32380090
[TBL] [Abstract][Full Text] [Related]
55. Synthesis and structure-activity relationships of allosteric potentiators of the m(4) muscarinic acetylcholine receptor.
Kennedy JP; Bridges TM; Gentry PR; Brogan JT; Kane AS; Jones CK; Brady AE; Shirey JK; Conn PJ; Lindsley CW
ChemMedChem; 2009 Oct; 4(10):1600-7. PubMed ID: 19705385
[No Abstract] [Full Text] [Related]
56. Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors.
Tränkle C; Weyand O; Voigtländer U; Mynett A; Lazareno S; Birdsall NJ; Mohr K
Mol Pharmacol; 2003 Jul; 64(1):180-90. PubMed ID: 12815174
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and evaluation of xanomeline analogs--probing the wash-resistant phenomenon at the M1 muscarinic acetylcholine receptor.
Kane BE; Grant MK; El-Fakahany EE; Ferguson DM
Bioorg Med Chem; 2008 Feb; 16(3):1376-92. PubMed ID: 17977730
[TBL] [Abstract][Full Text] [Related]
58. Challenges in the development of an M
Wood MR; Noetzel MJ; Poslusney MS; Melancon BJ; Tarr JC; Lamsal A; Chang S; Luscombe VB; Weiner RL; Cho HP; Bubser M; Jones CK; Niswender CM; Wood MW; Engers DW; Brandon NJ; Duggan ME; Conn PJ; Bridges TM; Lindsley CW
Bioorg Med Chem Lett; 2017 Jan; 27(2):171-175. PubMed ID: 27939174
[TBL] [Abstract][Full Text] [Related]
59. Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1-yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A₁ adenosine receptor.
Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Cruz-Lopez O; Salvador MK; Preti D; Tabrizi MA; Shryock JC; Moorman AR; Vincenzi F; Varani K; Borea PA
Bioorg Med Chem; 2012 Jan; 20(2):996-1007. PubMed ID: 22182575
[TBL] [Abstract][Full Text] [Related]
60. The muscarinic M(4) receptor is the functionally predominant subtype in rat and mouse striatum as demonstrated using [(35)S] GTPγS binding.
Chapman KL; Vaswani D; Hendry N; Langmead CJ; Kew JN; Watson JM
Eur J Pharmacol; 2011 Feb; 652(1-3):1-6. PubMed ID: 21114972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
